Shree Ganesh Bio-Tech Fair Value
Shree Ganesh Bio-Tech fair value. Shree Ganesh Bio-Tech (SHREEGANES) average fair value is ₹22.46 across 4 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF), vs a current market price of ₹0.47 (+4679.79%), fair value range ₹0.69–₹46.8. Check SHREEGANES market cap trends to track the company's total market size over time.
Fair Value Analysis Export
SHREEGANES Fair Value vs Current Price — Valuation Summary
SHREEGANES average fair value, fair value range, price gap and valuation status across 4 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF). Explore SHREEGANES intrinsic value to estimate fundamental worth using multiple valuation models.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Discounted Cash Flow (DCF)
SHREEGANES Fair Value Analysis — Data Sources & Coverage
Shree Ganesh Bio-Tech financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit Shree Ganesh Bio-Tech share price today.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
SHREEGANES vs Healthcare Sector Peers — P/E, P/B & Market Cap
Shree Ganesh Bio-Tech P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Emcure Pharmaceuticals | EMCURE | 35.85 | 7.38 | ₹37,156 |
| Divis Laboratories | DIVISLAB | 87.22 | 15.22 | ₹253,522 |
| Aurobindo Pharma | AUROPHARMA | 25.97 | 2.54 | ₹96,479 |
| Syngene International | SYNGENE | 65.37 | 2.98 | ₹14,538 |
| Sat Kartar Life | SATKARTAR | 16.56 | 4.14 | ₹307 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.